Amyloid-β associated volume loss occurs only in the presence of phospho-tau.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 22002658.
- Also identified by DOI 10.1002/ana.22509 and PMC identifier 3368003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The relationship between neurodegeneration and the 2 hallmark proteins of Alzheimer's disease, amyloid-β (Aβ) and tau, is still unclear. Here, we examined 286 nondemented participants (107 cognitively normal older adults and 179 memory impaired individuals) who underwent longitudinal magnetic resonance (MR) imaging and lumbar puncture. Using mixed effects models, we investigated the relationship between longitudinal entorhinal cortex atrophy rate, cerebrospinal fluid (CSF) p-tau(181p) and CSF Aβ(1-42) . We found a significant relationship between elevated entorhinal cortex atrophy rate and decreased CSF Aβ(1-42) only with elevated CSF p-tau(181p) . Our findings indicate that Aβ-associated volume loss occurs only in the presence of phospho-tau in humans at risk for dementia.
Medical subject headings
- Amnesia
- Amyloid beta-Peptides
- Cerebral Cortex
- Cognitive Dysfunction
- Peptide Fragments
- tau Proteins